Greenleaf Peter Insider Trades

Insider Trading History

Track insider trading activity for Greenleaf Peter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $32.9M 1,840,379 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.43M 100,890 shares
$14.21
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $34.7M 1,941,269 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.44M 524,827 shares
$14.17
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $31.2M 1,744,866 shares
Last Trade
Feb 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.44M 100,171 shares
$14.40
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $33M 1,845,037 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.81M 113,169 shares
$15.95
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $34.9M 1,954,329 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.54M 165,384 shares
$15.35
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $32M 1,788,945 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 164,947 shares
$7.92
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $34.9M 1,953,892 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56M 195,593 shares
$8.00
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $38.4M 2,149,485 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.66M 333,705 shares
$7.98
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $32.5M 1,815,780 shares
Last Trade
Feb 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.35M 443,973 shares
$7.55
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $27.2M 1,522,114 shares
Last Trade
Mar 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$711k 126,981 shares
$5.60
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $29.5M 1,649,095 shares
Last Trade
Feb 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.7M 661,538 shares
$5.59
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $17.6M 982,671 shares
Last Trade
Mar 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$290k 33,047 shares
$8.78
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $17.6M 982,968 shares
Last Trade
Mar 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$293k 32,750 shares
$8.94
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $18.2M 1,015,718 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.97M 667,407 shares
$8.94
$17.88
Antares Pharma
Antares Pharma ATRS
Director
Holding Value $0 0 shares
Last Trade
May 24, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.25M 222,942 shares
$5.59
$5.59
Biodelivery Sciences International
Biodelivery Sciences International BDSI
Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$587k 105,034 shares
$5.59
$5.59
Biodelivery Sciences International
Biodelivery Sciences International BDSI
Director
Holding Value $0 0 shares
Last Trade
Mar 22, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$359k 64,164 shares
$5.59
$5.59
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $5.58M 312,240 shares
Last Trade
Mar 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.63M 312,240 shares
$11.62
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Chief Executive Officer
Holding Value $589k 32,967 shares
Last Trade
Mar 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 9,068 shares
$12.01
$17.88
Biodelivery Sciences International
Biodelivery Sciences International BDSI
Director
Holding Value $639k 114,347 shares
Last Trade
Jan 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 114,347 shares
$3.66
$5.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up